Eastman Chemical (EMN) News Today

Eastman Chemical Company (NYSE: EMN) shares are under pressure following a string of earnings misses, lowered outlooks, and analyst downgrades. Investors are reacting to weaker-than-expected quarterly results, a cut in Q3 guidance, and reduced price targets.

• Neutral Sentiment: Review the Q2 2025 earnings call transcript for detailed commentary from management. EMN Q2 Earnings Call Transcript
• Neutral Sentiment: Access the Q2 results presentation slides for segment-level performance and financial breakdowns. EMN Q2 Results Presentation
• Negative Sentiment: Raised concerns with Q3 2025 EPS guidance of $1.25 versus a $1.915 consensus, signaling a softer outlook. Q3 Earnings Guidance
• Negative Sentiment: Mizuho trimmed its price target to $80 from $92, despite keeping an “outperform” rating. Price Target Lowered to $80
• Negative Sentiment: Q2 results missed views as EPS of $1.60 (vs. $1.72 consensus) and revenue of $2.29 B (vs. $2.32 B consensus). Q2 Earnings & Revenue Miss
• Negative Sentiment: Zacks Research cut its Q2 EPS estimate to $1.72 from $1.79 and lowered full-year forecasts. Q2 EPS Estimate Decreased
• Negative Sentiment: Tariff pressures are forcing inventory cuts and dragging on expected profits. Downbeat Profit Forecast
• Negative Sentiment: Shares plunged after management’s guidance update failed to meet investor expectations. Shares Plunge as Guidance Disappoints